182 related articles for article (PubMed ID: 631257)
1. Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.
Van Went GF
Experientia; 1978 Mar; 34(3):324-5. PubMed ID: 631257
[TBL] [Abstract][Full Text] [Related]
2. EEG effects of hallucinogens and cannabinoids using sleep-waking behavior as baseline.
Fairchild MD; Jenden DJ; Mickey MR; Yale C
Pharmacol Biochem Behav; 1980 Jan; 12(1):99-105. PubMed ID: 6102770
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacological action spectra of hallucinogens].
Waser PG
Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
[No Abstract] [Full Text] [Related]
4. d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
De Gregorio D; Enns JP; Nuñez NA; Posa L; Gobbi G
Prog Brain Res; 2018; 242():69-96. PubMed ID: 30471683
[TBL] [Abstract][Full Text] [Related]
5. A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats.
Cameron OG; Appel JB
Psychopharmacologia; 1973; 33(2):117-34. PubMed ID: 4272898
[No Abstract] [Full Text] [Related]
6. Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.
Abramson HA; Rolo A
J Asthma Res; 1965 Sep; 3(1):81-96. PubMed ID: 5318626
[No Abstract] [Full Text] [Related]
7. Serotonergic psychedelics LSD & psilocybin increase the fractal dimension of cortical brain activity in spatial and temporal domains.
Varley TF; Carhart-Harris R; Roseman L; Menon DK; Stamatakis EA
Neuroimage; 2020 Oct; 220():117049. PubMed ID: 32619708
[TBL] [Abstract][Full Text] [Related]
8. Cross tolerance between LSD and psilocybin.
ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
[No Abstract] [Full Text] [Related]
9. Psychotomimetic drugs: biochemistry and pharmacology.
Brimblecombe RW
Adv Drug Res; 1973; 7():165-206. PubMed ID: 4613150
[No Abstract] [Full Text] [Related]
10. Comparison of the reactions induced by psilocybin and LSD-25 in man.
ISBELL H
Psychopharmacologia; 1959; 1():29-38. PubMed ID: 14405870
[No Abstract] [Full Text] [Related]
11. Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects.
Holze F; Ley L; Müller F; Becker AM; Straumann I; Vizeli P; Kuehne SS; Roder MA; Duthaler U; Kolaczynska KE; Varghese N; Eckert A; Liechti ME
Neuropsychopharmacology; 2022 May; 47(6):1180-1187. PubMed ID: 35217796
[TBL] [Abstract][Full Text] [Related]
12. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
HOLFELD H
Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
[No Abstract] [Full Text] [Related]
13. The hallucinogens and the inhalants.
Cohen S
Psychiatr Clin North Am; 1984 Dec; 7(4):681-8. PubMed ID: 6097885
[TBL] [Abstract][Full Text] [Related]
14. Hypersensitivity to lysergic acid diethylamide (LSD-25) and psilocybin in essential headache.
Fanciullacci M; Franchi G; Sicuteri F
Experientia; 1974 Dec; 30(12):1441-3. PubMed ID: 4442544
[No Abstract] [Full Text] [Related]
15. The effect of delta 9-tetrahydrocannabinol and LSD on the acquisition of an active avoidance response in the rat.
Waser PG; Martin A; Heer-Carcano L
Psychopharmacologia; 1976 Apr; 46(3):249-54. PubMed ID: 951460
[TBL] [Abstract][Full Text] [Related]
16. The pharmacology of hallucinogens.
Brawley P; Duffield JC
Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
[No Abstract] [Full Text] [Related]
17. Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.
Lyvers M; Meester M
J Psychoactive Drugs; 2012; 44(5):410-7. PubMed ID: 23457892
[TBL] [Abstract][Full Text] [Related]
18. On travels in the universe of the soul: reports on self-experiments with delysid (LSD) and psilocybin (CY).
Gelpke R
J Psychoactive Drugs; 1981; 13(1):81-9. PubMed ID: 7024496
[No Abstract] [Full Text] [Related]
19. Neurological aspects of hallucinogenic drugs.
Logan WJ
Adv Neurol; 1975; 13():47-78. PubMed ID: 814800
[No Abstract] [Full Text] [Related]
20. Hallucinogens and dominance behavior of the rat.
Uyeno ET
Proc West Pharmacol Soc; 1967; 10():94. PubMed ID: 6055511
[No Abstract] [Full Text] [Related]
[Next] [New Search]
